Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—part 1

References

• Peacock WF. Short stay management of heart failure1st ed. Lippincott, Williams & Wilkins, Philadelphia, Pa 2006
   Google Scholar
• Hunt S, Abraham W, Chin M, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005; 112: e156
   Google Scholar
• Russo, M. The cost of end stage heart failure. Scientific session presented at: American Heart Association Cardiology Conference; November 12–15, 2006; Chicago, IL.
   Google Scholar
• Fonarow GC, Adams KFJR, Abraham WT, Yancy CW, Boscardin WJ. For the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005; 293: 572–80
   PubMed Web of Science ®Google Scholar
• Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 384–416
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958–68
   PubMed Web of Science ®Google Scholar
• Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baughman KL, et al. For the Heart Failure Society of America. HFSA comprehensive heart failure practice guideline. J Card Fail. ;12 2006; 2006: e1–e122
   Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002; 347: 161–7
   PubMed Web of Science ®Google Scholar
• Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001; 37: 379–85
   PubMed Web of Science ®Google Scholar
• Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27: 2725–36
   PubMed Web of Science ®Google Scholar
• McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416–22
   PubMed Web of Science ®Google Scholar
• Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002; 39: 131–8
   PubMed Web of Science ®Google Scholar
• Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA. 2005; 294: 1944–56
   PubMed Web of Science ®Google Scholar
• Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults?. JAMA. 1997; 277: 1712–9
   PubMedGoogle Scholar
• Collins, SP, Lindsell, CJ, Storrow, AB, Abraham, WT, and the Adhere Scientific Advisory Committee IaSG. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med. 2006;47:13–8.
   PubMed Web of Science ®Google Scholar
• Chakko S, Woska D, Martinez H, De Marchena E, Futterman L, Kessler KM, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991; 90: 353–9
   PubMed Web of Science ®Google Scholar
• Januzzi JL, van Kimmenade R, Lainchbury J, Bayés-Genís A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006; 27: 330–7
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005; 95: 948–54
   PubMed Web of Science ®Google Scholar
• Knudsen CW, Clopton P, Westheim A, Klemsdal TO, Wu AHB, Duc P, et al. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the Breathing Not Properly Multinational Study. Ann Emerg Med. 2005; 45: 573–80
   Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC, Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002; 40: 976–82
   PubMed Web of Science ®Google Scholar
• McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003; 41: 571–9
   PubMed Web of Science ®Google Scholar
• Summers RL, Shoemaker WC, Peacock WF, Ander DS, Coleman TG. Bench to bedside: electrophysiologic and clinical principles of noninvasive hemodynamic monitoring using impedance cardiography. Acad Emerg Med. 2003; 10: 669–80
   PubMed Web of Science ®Google Scholar
• Springfield CL, Sebat F, Johnson D, Lengle S, Sebat C. Utility of impedance cardiography to determine cardiac vs noncardiac cause of dyspnea in the emergency department. Congest Heart Fail 2004; 10((Suppl 2))14–6
   Google Scholar
• Neath SX, Lazio L, Guss DA. Utility of impedance cardiography to improve physician estimation of hemodynamic parameters in the emergency department. Congest Heart Fail. 2005; 11: 17–20
   PubMedGoogle Scholar
• Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001; 103: 369–74
   PubMed Web of Science ®Google Scholar
• Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116: 1242–9
   PubMed Web of Science ®Google Scholar
• West JA, Miller NH, Parker KM, Senneca D, Ghandour G, Clark M, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997; 79: 58–63
   PubMed Web of Science ®Google Scholar
• Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333: 1190–5
   PubMed Web of Science ®Google Scholar
• Philbin EF. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure. J Gen Intern Med. 1999; 14: 130–5
   Google Scholar
• Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 1992; 20: 1549–55
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. Nonsteroidal anti-inflammatory drugs as a trigger of clinical heart failure. Epidemiology 2003; 14: 240–6
   PubMed Web of Science ®Google Scholar
• Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004; 10: 101–12
   Google Scholar
• Cleland JGF, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004; 148: 157–64
   PubMed Web of Science ®Google Scholar
• Betkowski AS, Graff R, Chen JJ, Hauptman PJ. Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant. 2002; 21: 644–50
   Google Scholar
• Goldberger JJ, Peled HB, Stroh JA, Cohen MN, Frishman WH. Prognostic factors in acute pulmonary edema. Arch Intern Med. 1986; 146: 489–93
   PubMedGoogle Scholar
• Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998; 32: 695–703
   PubMed Web of Science ®Google Scholar
• Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989; 261: 884–8
   PubMed Web of Science ®Google Scholar
• Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail. 1999; 1: 251–7
   Google Scholar
• O'Connell JB, Bristow M. Economic impact of heart failure in the United States: a time for a different approach. J Heart Lung Transplant. 1994; 13: S107–12
   PubMed Web of Science ®Google Scholar
• Stevenson LW, Braunwald E. Recognition and management of patients with heart failure. Primary Cardiology, L Goldman, E Braunwald. WB Saunders, Philadelphia, Pa 1998; 310–29
   Google Scholar
• American Heart Association. Heart disease and stroke statistics-2004 update. Available at: http://www.americanheart.org/downloadable/heart/ 1079736729696HDSStats2004UpdateREV3-19-04.pdf. Accessed December 24, 2007.
   Google Scholar
• Graff L, Orledge J, Radford MJ, Wang Y, Petrillo M, Maag R, et al. Correlation of the agency for health care policy and research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann Emerg Med. 1999; 34: 429–37
   PubMed Web of Science ®Google Scholar
• Smith WR, Poses RM, McClish DK, Huber EC, Clemo FLW, Alexander D, et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest 2002; 121: 1610–7
   Google Scholar
• Polanczyk CA, Rohde LE, Philbin EA, Di Salvo TG. A new casemix adjustment index for hospital mortality among patients with congestive heart failure. Med Care. 1998; 36: 1489–99
   Google Scholar
• Adams KF, Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149: 209–16
   PubMed Web of Science ®Google Scholar
• Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24: 442–63
   PubMed Web of Science ®Google Scholar
• Cuffe MS, Califf RM, Adams KF, Jr, Benza R, Bourge R, Colucci WS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002; 287: 1541–7
   PubMed Web of Science ®Google Scholar
• Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531–40.
   PubMed Web of Science ®Google Scholar
• Rame JE, Sheffield MA, Dries DL, Gardner EB, Toto KH, Yancy CW, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 2001; 142: 714–9
   PubMed Web of Science ®Google Scholar
• Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult-summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. ;46 2005; 2005: 1116–43
   Google Scholar
• Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002; 21: 189–203
   PubMed Web of Science ®Google Scholar
• Heart Failure Society of America. HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction—pharmacological approaches. Congest Heart Fail. 2000;6:11–39.
   Google Scholar
• Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–98.
   PubMed Web of Science ®Google Scholar
• Konstam, M, Dracup, K, Baker, D. Clinical Practice Guidelines No 11: heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Provid Stud Res Note Agency Health Care Policy Res. 1994;94.
   Google Scholar
• Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al. For the OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatment and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007; 50: 768–77
   PubMed Web of Science ®Google Scholar
• Selker HP, Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care 1994; 32: 1040–52
   Google Scholar
• Chin MH, Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med. 1996; 156: 1814–20
   PubMed Web of Science ®Google Scholar
• Katz MH, Nicholson BW, Singer DE, Kelleher PA, Mulley AG, Thibault GE. The triage decision in pulmonary edema. J Gen Intern Med. 1988; 3: 533–9
   Google Scholar
• Fonarow GC, Adams KF, Jr, Abraham WT, Yancy CW, Boscardin WJ. For the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005; 293: 572–80
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. For the OPTIMIZE- HF [Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure] Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296: 2217–26
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, Stough WG, Greenberg BH, O'Connor CM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007; 28: 980–8
   PubMed Web of Science ®Google Scholar
• Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 2007; 13: 360–4
   PubMed Web of Science ®Google Scholar
• Formiga F, Chivite D, Manito N, Casas S, Riera A, Pujol R. Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology 2007; 108: 73–8
   Web of Science ®Google Scholar
• Diercks DB, Peacock WF, Kirk JD, Weber JE. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006; 24: 319–24
   Google Scholar
• Auble TE, Hsieh M, Gardner W, Cooper GF, Stone RA, McCausland JB, et al. A prediction rule to identify low-risk patients with heart failure. Acad Emerg Med. 2005; 12: 514–21
   PubMed Web of Science ®Google Scholar
• Bayés-Genís A, Lopez L, Zapico E, Cotes C, Santaló M, Ordonez-Llanos J, et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail. 2005; 11: S3–8
   PubMed Web of Science ®Google Scholar
• Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002; 39: 131–8
   PubMed Web of Science ®Google Scholar
• Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001; 37: 386–91
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007; 49: 1943–50
   PubMed Web of Science ®Google Scholar
• Januzzi JL, van Kimmenade R, Lainchbury J, Bayés-Genís A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006; 27: 330–7
   PubMed Web of Science ®Google Scholar
• Yu CM, Sanderson JE. Plasma brain natriuretic peptide—an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail. 1999; 1: 59–65
   PubMed Web of Science ®Google Scholar
• Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol. 2004; 44: 1328–33
   PubMed Web of Science ®Google Scholar
• Kirk V, Bay M, Parner J, Krogsgaard K, Herzog TM, Boesgaard S, et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail. 2004; 6: 335–41
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Jr, Sakhuja R, O'Donoghue M, Baggish AL, Anwaruddin S, Chae CU, et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med. 2006; 166: 315–20
   PubMedGoogle Scholar
• Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J. 2006; 27: 839–45
   PubMed Web of Science ®Google Scholar
• Heart Failure Society of America. HFSA. 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12:e1–2.
   Google Scholar
• Silvers SM, Howell JM, Kosowsky JM, Rokos IC, Jagoda AS. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med. 2007; 49: 627–69
   PubMed Web of Science ®Google Scholar
• Peacock WF, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am. 2001; 19: 209–32
   PubMed Web of Science ®Google Scholar
• Peacock WF, Young J, Collins S, Diercks D, Emerman C. Heart failure observation units: optimizing care. Ann Emerg Med. 2006; 47: 22–33
   PubMed Web of Science ®Google Scholar
• Storrow AB, Collins SP, Lyons MS, Wagoner LE, Gibler WB, Lindsell CJ. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail. 2005; 11: 68–72
   Google Scholar
• Ivanov RI, Allen J, Sandham JD, Calvin JE. Pulmonary artery catheterization: a narrative and systematic critique of randomized controlled trials and recommendations for the future. New Horiz. 1997; 5: 268–76
   PubMedGoogle Scholar
• Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005; 294: 1625–33
   PubMed Web of Science ®Google Scholar
• Brophy JM, Deslauriers G, Boucher B, Rouleau JL. The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1993; 9: 219–24
   Google Scholar
• Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1994; 10: 543–7
   PubMed Web of Science ®Google Scholar
• O'Neill JO, Bott-Silverman CE, McRae AT III, Troughton RW, Ng K, Starling R, et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J. 2005; 149: 363–9
   Google Scholar
• Kazanegra R, Cheng V, Gaccia A, Krishnaswamy P, Gasdetto N, Clopton P, et al. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001; 7: 21–9
   PubMed Web of Science ®Google Scholar
• Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006; 152: 828–34
   PubMed Web of Science ®Google Scholar
• Valle R, Prevaldi C, D'Eri A, Fontebasso A, Giovinazzo P, Noventa F, et al. B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema. Am J Geriatr Cardiol. 2006; 15: 202–7
   Google Scholar
• Verdiani V, Nozzoli C, Bacci F, Cecchin A, Rutili MS, Paladini S, et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail. 2005; 7: 566–71
   PubMed Web of Science ®Google Scholar
• Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004; 43: 635–41
   PubMed Web of Science ®Google Scholar
• Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126–30
   PubMed Web of Science ®Google Scholar
• Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990; 38: 1290–5
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002; 39: 83–9
   PubMed Web of Science ®Google Scholar
• Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333: 1190–5
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005; 96(Suppl. 6A)11G–7
   Google Scholar
• Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005; 112: 3958–68
   PubMed Web of Science ®Google Scholar
• Cotter G, Moshkovitz Y, Milovanov O, Salah A, Blatt A, Krakover R, et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail. 2002; 4: 227–34
   Web of Science ®Google Scholar
• Adams KF, Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149: 209–16
   PubMed Web of Science ®Google Scholar
• Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24: 442–63
   PubMed Web of Science ®Google Scholar
• Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baughman KL, et al. For the Heart Failure Society of America. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006; 12: e1–e122
   PubMedGoogle Scholar
• Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 384–416
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Mebazaa A. Introduction to acute heart failure syndromes. Am J Cardiol. 2005; 96(Suppl. 6A)1G–4G
   Google Scholar
• Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol. 2005; 96(Suppl)47G–58G
   Google Scholar
• Brater DC. Diuretic therapy. N Engl J Med. 1998; 339: 387–95
   PubMed Web of Science ®Google Scholar
• Stough WG, O'Connor CM, Gheorghiade M. Overview of current noninodilator therapies for acute heart failure syndromes. Am J Cardiol. 2005; 96(Suppl)41G–6G
   Google Scholar
• Moazemi K, Chana JS, Willard AM, Kocheril AG. Intravenous vasodilator therapy in congestive heart failure. Drugs Aging. 2003; 20: 485–508
   PubMed Web of Science ®Google Scholar
• Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M. Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations. J Cardiovasc Pharmacol Ther. 2004; 9: 227–41
   Google Scholar
• Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348–53
   PubMed Web of Science ®Google Scholar
• Jhund PS, McMurray J, Davie AP. The acute vascular effects of furosemide in heart failure. Br J Clin Pharmacol. 2000; 50: 9–13
   Google Scholar
• Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J. 1999; 138: 285–90
   PubMed Web of Science ®Google Scholar
• Cooper HA, Dries DL, Davis CE, Shen YI, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100: 1311–5
   PubMed Web of Science ®Google Scholar
• Lahav M, Regev A, Ra'anani P. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992; 102: 725–31
   PubMedGoogle Scholar
• Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996; 28: 376–82
   PubMed Web of Science ®Google Scholar
• Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997; 62: 187–93
   Web of Science ®Google Scholar
• Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389–93
   PubMed Web of Science ®Google Scholar
• Heywood, JT. Temporal characteristics of serum creatinine elevations in patients receiving nesiritide and nitroglycerin. Presented at: Heart Failure Society of America 9th Annual Scientific Sessions; September 20, 2005; Boca Raton, Fl. Abstract 255.
   Google Scholar
• Burger, AJ. Clinical predictors of worsening renal function in patients hospitalized for heart failure. Presented at: Heart Failure Society of America 9th Annual Scientific Sessions; September 19, 2005; Boca Raton, Fl. Abstract 345.
   Google Scholar
• Elkayam U, Roth A, Kumar A, Kulick D, McIntosh N, McKay CR, et al. Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation. Am J Cardiol. 1987; 60: 1106–11
   Google Scholar
• Loh E, Elkayam U, Cody R, Bristow M, Jaski B, Colucci WS. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. J Card Fail. 2001; 7: 114–21
   Google Scholar
• Nashed AH, Allegra JR. Intravenous nitroglycerin boluses in treating patients with cardiogenic pulmonary edema. Am J Emerg Med. 1995; 13: 612–3
   Google Scholar
• Nashed A, Allegra JR, Eskin B, Garg S, Roche LM. Prospective trial of the treatment of acute cardiogenic pulmonary edema with IV nitroglycerin boluses. Ann Emerg Med. 1997; 30: 382
   Google Scholar
• Cotter G, Faibel H, Barash P, Shemesh E, Moshkovitz Y, Metzkor E, et al. High-dose nitrates in the immediate management of unstable angina: optimal dosage, route of administration, and therapeutic goals. Am J Emerg Med. 1998; 16: 219–24
   Google Scholar
• Levy P, Hexdall A, Gordon P, Boeriu C, Arafat R. A randomized trial of bolus nitroglycerin for the treatment of acute congestive heart failure. Acad Emerg Med. 2003; 10: 544b–5b
   Google Scholar
• Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007; 50: 144–52
   PubMed Web of Science ®Google Scholar
• Levy PD, Compton S, Welch R, Delgado G, Penugonda N, Dunne R, et al. Need for mechanical ventilation is reduced by the use of high-dose nitroglycerin for patients with acute cardiogenic pulmonary edema: results of an open-label trial. Acad Emerg Med. 2006; 13: s107
   Google Scholar
• Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531–40.
   PubMed Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998; 339: 321–8
   PubMed Web of Science ®Google Scholar
• Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA, et al. For the Natrecor Study Group. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol. 1999; 34: 155–62
   PubMed Web of Science ®Google Scholar
• Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, et al. For the Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000; 343: 246–53
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005; 111: 1487–91
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005; 293: 1900–5
   PubMed Web of Science ®Google Scholar
• Abraham WT. Nesiritide and mortality risk: individual and pooled analyses of randomized controlled trials. Rev Cardiovasc Med. 2005; 6: 2
   Google Scholar
• Teerlink J, Massie BM. Nesiritide and worsening of renal function: the emperor's new clothes?. Circulation. 2005; 111: 1459–61
   PubMed Web of Science ®Google Scholar
• The Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429–35.
   Google Scholar
• The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302.
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–91.
   PubMed Web of Science ®Google Scholar
• Hamilton RJ, Carter WA, Gallagher EJ. Rapid improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med. 1996; 3: 205–12
   Google Scholar
• Annane D, Bellissant E, Pussard E, Asmar R, Lacombe F, Lanata E, et al. Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation 1996; 94: 1316–24
   PubMedGoogle Scholar
• Sacchetti A, Ramoska E, Moakes ME, McDermott P, Moyer V. Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med. 1999; 17: 571–4
   PubMed Web of Science ®Google Scholar
• Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest 1987; 92: 586–93
   PubMed Web of Science ®Google Scholar
• Peacock WF, Hollander J, Diercks D, Fonorow G, Emerman CL. Morphine for acute decompensated heart failure: valuable adjunct or a historical remnant?. Acad Emerg Med. 2005; 12: 97b–8b
   Google Scholar
• Collins SP, Mielniczuk LM, Whittingham HA, Boseley ME, Schramm DR, Storrow AB. The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review. Ann Emerg Med. 2006; 48: 260–9, 9 e1–4.
   PubMed Web of Science ®Google Scholar
• Mehta S, Jay GD, Woolard RH, Hipona RA, Connolly EM, Cimini DM, et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med. 1997; 25: 620–8
   PubMed Web of Science ®Google Scholar
• Philip-Joet FF, Paganelli FF, Dutau HL, Saadjian AY. Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure. Respiration. 1999; 66: 136–43
   PubMed Web of Science ®Google Scholar
• Levitt MA. A prospective, randomized trial of BiPAP in severe acute congestive heart failure. J Emerg Med. 2001; 21: 363–9
   PubMed Web of Science ®Google Scholar
• Nava S, Carbone G, DiBattista N, Bellone A, Baiardi P, Cosentini R, et al. Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. Am J Respir Crit Care Med. 2003; 168: 1432–7
   PubMed Web of Science ®Google Scholar
• Masip J, Roque M, Sánchez B, Fernández R, Subirana M, Expósito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005; 294: 3124–30
   PubMed Web of Science ®Google Scholar
• Cleland JG, Abdellah AT, Khaleva O, Coletta AP, Clark AL. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. Eur J Heart Fail. 2007; 9: 1070–3, Epub 2007 Sep 24.
   Google Scholar
• Pang D, Keenan SP, Cook DJ, Sibbald WJ. The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. Chest 1998; 114: 1185–92
   PubMed Web of Science ®Google Scholar
• Yan AT, Bradley TD, Liu PP. The role of continuous positive airway pressure in the treatment of congestive heart failure. Chest 2001; 120: 1675–85
   Google Scholar
• Masip J, Paez J, Merino M, Parejo S, Vecilla F, Riera C, et al. Risk factors for intubation as a guide for noninvasive ventilation in patients with severe acute cardiogenic pulmonary edema. Intensive Care Med. 2003; 29: 1921–8
   Google Scholar
• Gheorghiade M, Mebazaa A. The challenge of acute heart failure syndromes. Am J Cardiol. 2005; 96(Suppl. 6A)86G–9G
   Google Scholar
• Kirk JD, Costanza MR. Managing patients with acute decompensated heart failure. Clin Courier 2006; 23: 1–14
   Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. For the OPTIMIZE- HF [Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure] Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296: 2217–26
   PubMed Web of Science ®Google Scholar
• Filippatos G, Zannad F. An introduction to acute heart failure syndromes: definition and classification. Heart Fail Rev. 2007; 12: 87–90
   Google Scholar
• Bussmann W, Schupp D. Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema. Am J Cardiol. 1978; 41: 931–6
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Adams KF, Jr, Abraham WT, Yancy CW, Boscardin WJ. For the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005; 293: 572–80
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006; 119: S3–S10
   PubMed Web of Science ®Google Scholar
• Adams KF, Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149: 209–16
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. For the OPTIMIZE- HF [Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure] Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296: 2217–26
   PubMed Web of Science ®Google Scholar
• Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24: 442–63
   PubMed Web of Science ®Google Scholar
• O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF Registry. J Card Fail. 2005; 11: 200–5
   PubMed Web of Science ®Google Scholar
• Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M. On behalf of the IMPACT-HF investigators and coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. Results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004; 43: 1534–41
   PubMed Web of Science ®Google Scholar
• Yu CM, Wang L, Chau E, Chan RHW, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112: 841–8
   PubMed Web of Science ®Google Scholar
• Teerlink JR. Dyspnea as an end point in clinical trials therapies for acute decompensated heart failure. Am Heart J. 2003; 145: S26–S33
   Google Scholar
• Beck da Silva L, Mielniczuk L, Laberge M, Anselm A, Fraser M, Williams K, et al. Persistent orthopnea and the prognosis of patients in the heart failure clinic. Congest Heart Fail. 2004; 10: 177–80
   PubMedGoogle Scholar
• Shah MR, Hasselblad V, Gheorghiade M, Adams KF, Jr, Swedberg K, Califf RM, et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2001; 88: 987–93
   PubMed Web of Science ®Google Scholar
• Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail. 2003; 5: 247–52
   PubMed Web of Science ®Google Scholar
• Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distention. J Am Coll Cardiol. 1993; 22: 968–74
   Google Scholar
• Drazner MH, Rame JE, Phil M, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001; 345: 574–81
   PubMed Web of Science ®Google Scholar
• Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. JAMA. 2003; 290: 2581–7
   PubMed Web of Science ®Google Scholar
• The Joint Commission. A comprehensive review of development for core measures. Available at: http://www.jointcommission.org/NR/rdonlyres/48DFC95A-9C05-4A44-AB05=769D5253014/0/AComprehensiveReviewofDevelopmentforCoreMeasures.pdf, , accessed November 17, 2007.
   Google Scholar
• Sica DA. Hyponatremia and heart failure—pathophysiology and implications. Congest Heart Fail. 2005; 11: 274–7
   Google Scholar
• Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol. 2005; 95: 2B–7B
   PubMed Web of Science ®Google Scholar
• Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, et al. Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004; 43: 61–7
   PubMed Web of Science ®Google Scholar
• Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004; 43: 635–41
   PubMed Web of Science ®Google Scholar
• Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, et al. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001; 7: 21–9
   PubMed Web of Science ®Google Scholar
• Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001; 37: 386–91
   PubMed Web of Science ®Google Scholar
• Harrison A, Morrison L, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002; 39: 131–8
   PubMed Web of Science ®Google Scholar
• Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol. 2004; 44: 1328–33
   PubMed Web of Science ®Google Scholar
• Heart Failure Society of American. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12:e1–2.
   Google Scholar
• Michalsen, A, Konig, G, Thimme, W . Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998;437–41.
   Google Scholar
• Vinson JM. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990; 38: 1290–5
   PubMed Web of Science ®Google Scholar
• Whellan D, Gattis W, Gaulden L, O'Connor C. Disease management of congestive heart failure. Am J Manag Care 1999; 5: 499–507
   Google Scholar
• Rich MW, Vinson JM, Sperry JC, Shah AS, Spinner LR, Chung MK, et al. Prevention of readmissions in elderly patient with CHF. Results of a prospective, randomized pilot study. J Gen Intern Med. 1993; 8: 585–90
   PubMedGoogle Scholar
• Compliance or concordance: Is there a difference?. Drugs Ther Perspect. 1999; 13:11–2.
   Google Scholar
• Hunt S, Abraham W, Chin M, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation ;112:ee235 2005; 2005: 154
   Google Scholar
• Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baughman KL, et al. Executive summary: HFSA : comprehensive heart failure practice guideline. J Card Fail. ;12 2006; 2006: 10–38
   Google Scholar
• Cole J, Weatherby L, Walker A. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006; 26: 1157–64
   PubMed Web of Science ®Google Scholar
• Granger B, Swedberg K, Elkman I, Granger C, Olofsson B, McMurray J, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366: 2005–11
   PubMed Web of Science ®Google Scholar
• Hope C, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004; 61: 2043–9
   PubMed Web of Science ®Google Scholar
• Peacock WF, Young J, Collins S, Diercks D, Emerman C. Heart failure observation units: optimizing care. Ann Emerg Med. 2006; 47: 22–33
   PubMed Web of Science ®Google Scholar
• Storrow AB, Collins SP, Lyons MS, Wagoner LE, Gibler WB, Lindsell CJ. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail. 2005; 11: 68–72
   Google Scholar
• Peacock WF, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am. 2001; 19: 209–32
   PubMed Web of Science ®Google Scholar
• Esler JL, Bock BC. Psychological treatments for noncardiac chest pain: recommendations for a new approach. J Psychosom Res. 2004; 56: 263–9
   PubMed Web of Science ®Google Scholar
• Williams S, Brown A, Patton R, Crawford MJ, Touquet R. The half-life of the'teachable moment' for alcohol misusing patients in the emergency department. Drug Alcohol Depend. 2005; 77: 205–8
   PubMed Web of Science ®Google Scholar
• Dominique J, Quervain DD, Roozendaal B, Nitsch R, McGaugh J, Hock C. Acute cortisol administration impairs retrieval of long term declarative memory in humans. Nat Neurosci. 2000; 3: 313–4
   Google Scholar
• Dunbar S, Clark P, Deaton C, Smith A, De A, O'Brien M. Family education and support interventions in heart failure. Nurs Res. 2005; 54: 1158–66
   Google Scholar
• Levanthal M. Negotiating Compliance in Heart Failure: Remaining Issues and Questions. Eur J Cardiovasc Nurs. 2005; 4: 298–307
   Google Scholar
• Doughty R, Wright S, Pearl A, Walsh HJ, Muncaster S, Whalley GA, et al. Randomized, controlled trial of integrated heart failure management: the Auckland heart failure management study. Eur Heart J. 2002; 23: 139–46
   PubMed Web of Science ®Google Scholar
• Ducharme A, Doyon O, White M. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. Can Med Assoc J. 2005; 173: 40–5
   PubMed Web of Science ®Google Scholar
• Rich M, Gray D, Beckham V. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996; 101: 270–6
   PubMed Web of Science ®Google Scholar
• Smith B, Forkner E, Zaslow B, Krasuski RA, Stajduhar K, Kwan M, et al. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Am J Manag Care 2005; 11: 701–13
   PubMed Web of Science ®Google Scholar
• Bouvy M, Heerdink E, Urquhart J. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003; 9: 404–11
   Web of Science ®Google Scholar
• Murray M, Young J, Hoke S, Wanzhu Tu, Weiner M, Morrow D, et al. Pharmacist intervention to improve medication adherence in heart failure: A randomized trial. Ann Intern Med. 2007; 146: 714–25
   PubMed Web of Science ®Google Scholar
• Varma S, McElnay J, Hughes C, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19: 860–9
   Web of Science ®Google Scholar
• Morrow D, Weiner M, Young J, Steinley D, Deer M, Murray MD. Improving medication knowledge among older adults with heart failure: a patient-centered approach to instruction design. Gerontologist 2005; 45: 545–52
   PubMed Web of Science ®Google Scholar
• Cook, NR , Cutler, JA , Obarzenak, E , Buring, JE , Rexrode, KM , Kumanyika, SK , , et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOPH). BMJ [serial online]. 2007; doi:10.1136/bmj.39147.604896.55.
   Google Scholar
• Gheorghiade, M , Abraham, WT , Albert, NM , Stough, WG , Greenberg, BH , O'Connor, CM , , et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007; doi:10.1093/eurheartj/ehl542.
   Google Scholar
• Goldberg L, Piette J, Walsh M, Frank TA, Jasli BE, Smith AL, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003; 146: 705–12
   PubMed Web of Science ®Google Scholar
• Chakko S, Woska D, Martinez H, De Marchena E, Futterman L, Kessler KM, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991; 90: 353–9
   PubMed Web of Science ®Google Scholar
• Carlon B, Riegel B. Self-care abilities of patients with heart failure. Heart Lung 2001; 30: 351–9
   Google Scholar
• Adamson P, Magalski A, Braunschweig F. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003; 41: 565–71
   PubMed Web of Science ®Google Scholar
• Abraham W. Intrathoracic impedance monitoring for early detection of impending heart failure decompensation. Congest Heart Fail. 2007; 13: 113–5
   Google Scholar
• Yu CM, Wang L, Chau E, Chan RHW, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112: 841–8
   PubMed Web of Science ®Google Scholar
• Adamson, P , Smith, A , Abraham, W , Kleckner, KJ , Stadler, RW , Shih, A , , et al. Continuous autonomic assessment in patient with symptomatic heart failure. Circulation 2004; 110, 16: 2389–94.
   PubMed Web of Science ®Google Scholar